Europa-Marktprognose für menschliche Lebermodelle bis 2028 – Auswirkungen von COVID-19 und regionale Analyse nach Typ (Leberorganoide, Leber-auf-einem-Chip, 2D-Modelle, 3D-Bioprinting und andere), Anwendung (Arzneimittelentwicklung, Bildung und andere) und Endbenutzer (Pharma- und Biotechnologieunternehmen, Forschungsinstitute und andere)
TIPRE00026112 |
Pages: 119 |
Biotechnology |
Nov 2021
|
Type: Regional |
Status: Published
Der europäische Markt für menschliche Lebermodelle wird voraussichtlich von 84.347,25 Tausend US-Dollar im Jahr 2021 auf 1.87.244,81 Tausend US-Dollar im Jahr 2028 wachsen; Von 2021 bis 2028 wird ein durchschnittliches jährliches Wachstum von 12,1 % erwartet.\\n\\nDas Vereinigte Königreich, Deutschland, Frankreich, Italien und Spanien sind die wichtigsten Volkswirtschaften in Europa. Es wird erwartet, dass der zunehmende Fokus auf die Entwicklung von Alternativen für Tierversuchsmodelle das Marktwachstum ankurbeln wird. Mit der zunehmenden Forschung und Entwicklung in der Medizinindustrie ist die Zahl der in der Forschung verwendeten Tiere gestiegen. Diese Tiere werden in großen Mengen für präklinische Tests benötigt. Schmerzen, Leiden und Tod von Tieren bei wissenschaftlichen Experimenten sind seit langem ein Diskussionsthema. Mehrere Fälle zeigen, dass Tiermodelle die Reaktion des Körpers auf Arzneimittel nicht immer vorhersagen können, insbesondere bei Studien zur Arzneimitteltoxikologie. Dies liegt daran, dass sich der Stoffwechsel von Arzneimitteln und Toxinen beim Menschen erheblich von dem bei Tieren unterscheidet, was es nahezu unmöglich macht, den Arzneimittelstoffwechsel experimentell zu untersuchen Modelle wie Labornagetierarten. Der Bereich der alternativen Forschung hat sich in den letzten 30 Jahren beschleunigt. Darüber hinaus wurden in den letzten Jahren mehrere Vorschriften eingeführt, die den Einsatz von Tieren bei Forschungsaktivitäten in der Region einschränken. Methoden wie In-vitro-Tests , Zellkulturen, Computersimulationen und neue Bildgebungs-/Analysetechniken wurden als alternative Mittel für Drogen- und Chemikalientests vorgeschlagen, um den übermäßigen Einsatz von Tieren zu vermeiden. Zur Integration sind bioinformatische Werkzeuge, In-vitro-Zellkulturen, enzymatische Screenings und Modellorganismen erforderlich verschiedene Computermodelle. Der Einsatz moderner Analysetechniken, Datenerfassung und statistischer Methoden zur Analyse der Ergebnisse alternativer Protokolle kann zuverlässige Ergebnisse liefern. Darüber hinaus sind diese Methoden weniger zeitaufwändig und kosteneffizient und erfordern eine begrenzte Anzahl an Arbeitskräften. Mit dem Aufkommen dreidimensionaler (3D) Zellkulturen zur Herstellung von Organoiden werden relevantere menschliche Organoidmodelle erforscht, um sichere und wirksame Arzneimitteltests zu ermöglichen und so den Bedarf an Tierversuchen zu minimieren. Es gilt, alternative Testmodelle zu entwickeln, die eine möglichst körpernahe Umgebung bieten können. Verschiedene Institute sind an der Entwicklung alternativer Methoden für die Arzneimittelentwicklung und die biomedizinische Forschung beteiligt. Da Lebermodelle als Alternative zu Tiermodellen dienen können, wird erwartet, dass der derzeitige Fokus auf die Reduzierung des Einsatzes von Tieren in der Forschung das Wachstum des Marktes für menschliche Lebermodelle in Europa unterstützen wird. \\nVon COVID-19 ist Europa stark betroffen, insbesondere Frankreich und Russland. Der aktuelle COVID-19-Ausbruch hat die von der EU finanzierte Forschung nicht überrascht. Die MSCA der Europäischen Kommission unterstützt herausragende Forscher dabei, Lösungen für Herausforderungen zu finden, die durch die neuartige Coronavirus-Krankheit COVID-19 und andere Infektionskrankheiten entstehen. Um den Start klinischer Studien im Zusammenhang mit COVID-19 zu erleichtern, haben die Behörden außerdem beschleunigte Genehmigungsverfahren für die erste Bewertung von Genehmigungsanträgen zugelassen. Allerdings haben erneut auftretende COVID-19-Wellen aufgrund der Schließung klinischer Studienzentren gemischte Auswirkungen auf den Markt. Laut Phesis Analyse vom September 2020 erreichten die weltweiten Sperrungen klinischer Studienstandorte im Juni ihren Höhepunkt und waren nach einem anfänglichen Rückgang wieder gestiegen und hatten erhebliche Auswirkungen auf Studien der Phasen 2 und 3. Angesichts der zunehmenden globalen wirtschaftlichen Unsicherheit in allen Sektoren dürfte das Jahr 2021 für die meisten klinischen Entwicklungsorganisationen weltweit eine Herausforderung werden. Klinische Forschung ist für die Entwicklung neuer Behandlungen und ein besseres Verständnis von Krankheiten von entscheidender Bedeutung, und COVID-19 bringt viele Herausforderungen mit sich. Die Regierungen in der Region planen einen sicheren und nachhaltigen Neustart von Nicht-COVID-Studien. Im September 2020 haben die Daten des NIHR Clinical Research Network gezeigt, dass Nicht-COVID-Studien wieder aufgenommen werden, wobei 45 % der Studien für die Rekrutierung offen sind. Darüber hinaus werden Organoide von Forschern im Rahmen der EuroStemCell-Partnerschaft verwendet. Beispielsweise verlangsamte eine internationale Gruppe von Wissenschaftlern, darunter Forscher des IMBA-Instituts für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften, die SARS-CoV-2-Infektion in Organoiden und demonstrierte damit die potenzielle blockierende Wirkung eines Arzneimittels bereits in klinischen Studien. Die Forscher führen verschiedene Untersuchungen durch, um den COVID-19-Ausbruch zu bewältigen. Somit werden verstärkte Forschungsaktivitäten zu entscheidenden Chancen für den Markt führen.\\n\\nMit den neuen Funktionen und Technologien können Anbieter neue Kunden gewinnen und ihre Präsenz in aufstrebenden Märkten ausbauen. Dieser Faktor dürfte den europäischen Markt für menschliche Lebermodelle antreiben. Es wird erwartet, dass der europäische Markt für menschliche Lebermodelle im Prognosezeitraum mit einer guten jährlichen Wachstumsrate wachsen wird. \\n\\nUmsatz und Prognose des Marktes für menschliche Lebermodelle in Europa bis 2028 (in Tausend US-Dollar) \\n\\nMarktsegmentierung für menschliche Lebermodelle in Europa \\nEuropa Markt für menschliche Lebermodelle nach Typ\\n- Leberorganoide\\n- Leber auf einem Chip \\n- 2D-Modelle\\n- 3D-Bioprinting\\n- Andere\\nEuropa-Markt für menschliche Lebermodelle nach Anwendung\\n- Arzneimittelforschung\\n- Bildung\\n- Andere\\nEuropa-Markt für menschliche Lebermodelle nach Endbenutzer\\n- Pharmazeutik und Biotechnologie Unternehmen\\n- Forschungsinstitute \\n- Andere \\nEuropa Markt für menschliche Lebermodelle, nach Land\\n- Deutschland\\n- Frankreich\\n- Vereinigtes Königreich\\n- Italien \\n- Spanien\\n- Restliches Europa\\nEuropa Menschliche Lebermodelle Markt -Erwähnte Unternehmen \\n- BioIVT\\n- CELLINK\\n- CN Bio Innovations\\n- Cyprio\\n- Emulate, Inc.\\n- InSphero\\n- Kerafast\\n- Kirkstall\\n- MIMETAS BV\\n- THERMO FISHER SCIENTIFIC INC.\\n\\n
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Human Liver Models Market By Type
1.3.2 Europe Human Liver Models Market By Application
1.3.3 Europe Human Liver Models Market By End User
1.3.4 Europe Human Liver Models Market By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Human Liver Models Market Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Human Liver Models Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Surging Prevalence of Liver Diseases
5.1.2 Escalating Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Overpriced Liver Models
5.3 Market Opportunities
5.3.1 Growing focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Increasing Technological Advancements in Organ Printing
5.1 Impact analysis
6. Human Liver Models Market Europe Analysis
6.1 Europe Human Liver Models Market Revenue Forecast and Analysis
7. Europe Human Liver Models Market Analysis By Type
7.1 Overview
7.2 Europe Human Liver Models Market Revenue Share, by Type (2021 and 2028)
7.3 Liver Organoids
7.3.1 Overview
7.3.2 Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.4 Liver-on-a-chip
7.4.1 Overview
7.4.2 Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.5 2D Models
7.5.1 Overview
7.5.2 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.6 3D Bioprinting
7.6.1 Overview
7.6.2 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.7 Others
7.7.1 Overview
7.7.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8. Europe Human Liver Models Market Analysis By Application
8.1 Overview
8.2 Europe Human Liver Models Market Share, by Application, 2021 and 2028, (%)
8.3 Educational
8.3.1 Overview
8.3.2 Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.5 Other
8.5.1 Overview
8.5.2 Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9. Europe Human Liver Models Market Analysis By End User
9.1 Overview
9.2 Europe Human Liver Models Market Share, by End User, 2021 and 2028, (%)
9.3 Research Institutes
9.3.1 Overview
9.3.2 Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
10. Europe Human Liver Models Market Country Analysis
10.1 Europe: Human Liver Models Market
10.1.1 Overview
10.1.2 Europe: Human Liver Models Market, by Country, 2021 & 2028 (%)
10.1.2.1 Germany: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.1 Germany: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.2 Germany: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.3 Germany: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.4 Germany: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2 France: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.1 France: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.2 France: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.3 France: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.4 France: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3 UK: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.1 UK: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.2 UK: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.3 UK: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.4 UK: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4 Spain: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4.1 Spain: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4.2 Spain: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4.3 Spain: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4.4 Spain: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5 Italy: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5.1 Italy: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5.2 Italy: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5.3 Italy: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5.4 Italy: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6 Rest of Europe: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6.1 Rest of Europe: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6.2 Rest of Europe: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6.3 Rest of Europe: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6.4 Rest of Europe: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
11. Impact Of COVID-19 Pandemic on Europe Human Liver Models Market
11.1 Europe: Impact Assessment Of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Emulate, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CN Bio Innovations
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 MIMETAS BV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 InSphero
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioIVT
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 CELLINK
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Kerafast
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Cyprio
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Kirkstall
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Human Liver Models Market, Revenue and Forecast, 20192028 (US$ Thousand)
Table 2. Germany: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 3. Germany: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 4. Germany: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 5. France: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 6. France: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 7. France: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 8. UK: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 9. UK: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 10. UK: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Spain: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 12. Spain: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 13. Spain: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 14. Italy: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 15. Italy: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 16. Italy: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 17. Rest of Europe: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 18. Rest of Europe: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 19. Rest of Europe: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Human Liver Models Market Segmentation
Figure 2. Europe Human Liver Models Market Segmentation, By Country
Figure 3. Europe Human Liver Models Market Overview
Figure 4. Liver Organoids Held the Largest Share in 2020
Figure 5. The UK to Show Significant Growth During Forecast Period
Figure 6. Europe and PEST Analysis
Figure 7. Europe Human Liver Models Market Impact Analysis of Drivers and Restraints
Figure 8. Europe Human Liver Models Market Revenue Forecast and Analysis
Figure 9. Europe Human Liver Models Market Revenue Share, by Type (2021 and 2028)
Figure 10. Europe Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. Europe Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 12. Europe 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. Europe 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. Europe Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 15. Europe Human Liver Models Market Share, by Application, 2021 and 2028 (%)
Figure 16. Europe Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. Europe Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 18. Europe Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. Europe Human Liver Models Market Share, by End User, 2021 and 2028 (%)
Figure 20. Europe Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. Europe Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 22. Europe Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 23. Europe: Human Liver Models Market, by Key Country Revenue (2021) (USD Thousand)
Figure 24. Europe: Human Liver Models Market, by Country, 2021 & 2028 (%)
Figure 25. Germany: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. France: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 27. UK: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 28. Spain: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 29. Italy: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 30. Rest of Europe: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 31. Impact of COVID-19 Pandemic in European Country Markets
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Human Liver Models Market By Type
1.3.2 Europe Human Liver Models Market By Application
1.3.3 Europe Human Liver Models Market By End User
1.3.4 Europe Human Liver Models Market By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Human Liver Models Market Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Human Liver Models Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Surging Prevalence of Liver Diseases
5.1.2 Escalating Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Overpriced Liver Models
5.3 Market Opportunities
5.3.1 Growing focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Increasing Technological Advancements in Organ Printing
5.1 Impact analysis
6. Human Liver Models Market Europe Analysis
6.1 Europe Human Liver Models Market Revenue Forecast and Analysis
7. Europe Human Liver Models Market Analysis By Type
7.1 Overview
7.2 Europe Human Liver Models Market Revenue Share, by Type (2021 and 2028)
7.3 Liver Organoids
7.3.1 Overview
7.3.2 Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.4 Liver-on-a-chip
7.4.1 Overview
7.4.2 Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.5 2D Models
7.5.1 Overview
7.5.2 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.6 3D Bioprinting
7.6.1 Overview
7.6.2 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.7 Others
7.7.1 Overview
7.7.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8. Europe Human Liver Models Market Analysis By Application
8.1 Overview
8.2 Europe Human Liver Models Market Share, by Application, 2021 and 2028, (%)
8.3 Educational
8.3.1 Overview
8.3.2 Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.5 Other
8.5.1 Overview
8.5.2 Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9. Europe Human Liver Models Market Analysis By End User
9.1 Overview
9.2 Europe Human Liver Models Market Share, by End User, 2021 and 2028, (%)
9.3 Research Institutes
9.3.1 Overview
9.3.2 Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
10. Europe Human Liver Models Market Country Analysis
10.1 Europe: Human Liver Models Market
10.1.1 Overview
10.1.2 Europe: Human Liver Models Market, by Country, 2021 & 2028 (%)
10.1.2.1 Germany: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.1 Germany: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.2 Germany: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.3 Germany: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.4 Germany: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2 France: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.1 France: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.2 France: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.3 France: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.4 France: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3 UK: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.1 UK: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.2 UK: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.3 UK: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.4 UK: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4 Spain: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4.1 Spain: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4.2 Spain: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4.3 Spain: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4.4 Spain: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5 Italy: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5.1 Italy: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5.2 Italy: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5.3 Italy: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5.4 Italy: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6 Rest of Europe: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6.1 Rest of Europe: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6.2 Rest of Europe: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6.3 Rest of Europe: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6.4 Rest of Europe: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
11. Impact Of COVID-19 Pandemic on Europe Human Liver Models Market
11.1 Europe: Impact Assessment Of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Emulate, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CN Bio Innovations
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 MIMETAS BV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 InSphero
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioIVT
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 CELLINK
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Kerafast
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Cyprio
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Kirkstall
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Human Liver Models Market, Revenue and Forecast, 20192028 (US$ Thousand)
Table 2. Germany: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 3. Germany: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 4. Germany: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 5. France: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 6. France: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 7. France: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 8. UK: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 9. UK: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 10. UK: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Spain: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 12. Spain: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 13. Spain: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 14. Italy: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 15. Italy: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 16. Italy: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 17. Rest of Europe: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 18. Rest of Europe: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 19. Rest of Europe: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Human Liver Models Market Segmentation
Figure 2. Europe Human Liver Models Market Segmentation, By Country
Figure 3. Europe Human Liver Models Market Overview
Figure 4. Liver Organoids Held the Largest Share in 2020
Figure 5. The UK to Show Significant Growth During Forecast Period
Figure 6. Europe and PEST Analysis
Figure 7. Europe Human Liver Models Market Impact Analysis of Drivers and Restraints
Figure 8. Europe Human Liver Models Market Revenue Forecast and Analysis
Figure 9. Europe Human Liver Models Market Revenue Share, by Type (2021 and 2028)
Figure 10. Europe Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. Europe Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 12. Europe 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. Europe 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. Europe Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 15. Europe Human Liver Models Market Share, by Application, 2021 and 2028 (%)
Figure 16. Europe Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. Europe Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 18. Europe Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. Europe Human Liver Models Market Share, by End User, 2021 and 2028 (%)
Figure 20. Europe Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. Europe Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 22. Europe Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 23. Europe: Human Liver Models Market, by Key Country Revenue (2021) (USD Thousand)
Figure 24. Europe: Human Liver Models Market, by Country, 2021 & 2028 (%)
Figure 25. Germany: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. France: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 27. UK: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 28. Spain: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 29. Italy: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 30. Rest of Europe: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 31. Impact of COVID-19 Pandemic in European Country Markets
1. BioIVT
2. CELLINK
3. CN Bio Innovations
4. Cyprio
5. Emulate, Inc.
6. InSphero
7. Kerafast
8. Kirkstall
9. MIMETAS BV
10. THERMO FISHER SCIENTIFIC INC.
2. CELLINK
3. CN Bio Innovations
4. Cyprio
5. Emulate, Inc.
6. InSphero
7. Kerafast
8. Kirkstall
9. MIMETAS BV
10. THERMO FISHER SCIENTIFIC INC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe human liver models market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe human liver models market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the human liver models market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Related Reports
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000